Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Kairos Pharma, Ltd. Common Stock (NY:KAPA)

1.170 UNCHANGED
Streaming Delayed Price Updated: 8:00 PM EDT, Jul 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,330,759
Open 1.170
Bid (Size) 1.050 (40)
Ask (Size) 1.060 (9)
Prev. Close 1.170
Today's Range 1.170 - 1.170
52wk Range 0.4000 - 4.000
Shares Outstanding 16,849,306
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Kairos Pharma Announces Participation and Presentation in the H.C. Wainwright 27th Annual Global Investment Conference September 8-10, 2025
From Kairos Pharma, Ltd
Via Business Wire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga

Performance

YTD
-23.5%
-23.5%
1 Month
+116.5%
+116.5%
3 Month
+18.9%
+18.9%
6 Month
-22.5%
-22.5%
1 Year
-55.0%
-55.0%

More News

Read More
Why Data Storage Shares Are Trading Higher By 35%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Tuesday's after hours session: top gainers and losers
Via Chartmill
Tech Momentum Surges as IPA, HIT, SNYR, PNPN.V, KAPA and Others Drive Investor Awareness – More Stocks Inside
Via AB Newswire
Topics Artificial Intelligence Earnings
Why Is Kairos Pharma Stock Surging On Tuesday?
Via Benzinga
Discover the most active stocks in Tuesday's session.
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Which stocks are moving on Tuesday?
Via Chartmill
Nasdaq Gains Over 100 Points; Wells Fargo Earnings Top Views
Via Benzinga
There are notable gap-ups and gap-downs in today's session.
Via Chartmill
BioMedNewsBreaks — Kairos Pharma Ltd. (NYSE American: KAPA) Reports Positive Safety Results in Phase 2 Study of Prostate Cancer Drug ENV-105
Via Investor Brand Network
Dow Falls Over 100 Points; JPMorgan Posts Upbeat Earnings
Via Benzinga
Topics Stocks
These stocks are moving in today's pre-market session
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Kairos Pharma Announces Positive Safety Results from Phase 2 Trial of ENV-105 in Advanced Prostate Cancer
From Kairos Pharma, Ltd
Via Business Wire
These stocks have an unusual volume in today's session
Via Chartmill
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
These stocks are moving in today's after hours session
Via Chartmill
The trading volume of these stocks is deviating from the norm in today's session.
Via Chartmill
These stocks are moving in today's pre-market session
Via Chartmill
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Why MongoDB Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga

Frequently Asked Questions

Is Kairos Pharma, Ltd. Common Stock publicly traded?
Yes, Kairos Pharma, Ltd. Common Stock is publicly traded.
What exchange does Kairos Pharma, Ltd. Common Stock trade on?
Kairos Pharma, Ltd. Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Kairos Pharma, Ltd. Common Stock?
The ticker symbol for Kairos Pharma, Ltd. Common Stock is KAPA on the New York Stock Exchange
What is the current price of Kairos Pharma, Ltd. Common Stock?
The current price of Kairos Pharma, Ltd. Common Stock is 1.170
When was Kairos Pharma, Ltd. Common Stock last traded?
The last trade of Kairos Pharma, Ltd. Common Stock was at 07/15/25 08:00 PM ET
What is the market capitalization of Kairos Pharma, Ltd. Common Stock?
The market capitalization of Kairos Pharma, Ltd. Common Stock is 19.71M
How many shares of Kairos Pharma, Ltd. Common Stock are outstanding?
Kairos Pharma, Ltd. Common Stock has 20M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.